Login | Users Online: 1414  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
Year : 2023  |  Volume : 24  |  Issue : 4  |  Page : 210-211

A case of ticagrelor-induced seizure

Department of Emergency Medicine, Health Science University, Antalya Training and Research Hospital, Antalya, Turkey

Correspondence Address:
Dr. Cihan Bedel
Department of Emergency Medicine, Health Science University Antalya Training and Research Hospital, Kazim Karabekir Street, Muratpasa, Antalya 07100
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/heartviews.heartviews_20_23

Rights and Permissions

Ticagrelor is available as an oral antiplatelet agent that can bind reversibly to the adenosine diphosphate receptor P2Y12 on platelets without first having to be activated. Main side effects such as dizziness, bleeding gums, nausea in common, difficulty in speaking, fever, and change in mental status are rare. Herein, we report a patient who had seizures after the usage of ticagrelor.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal